The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Human Immunodeficiency Virus (HIV)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., et al. (1999) · Nature · doi:10.1038/17130 · Cited by 1,763
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Origins of HIV and the AIDS Pandemic
Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496
Immune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D'Aquila, R. T., Goulder, P. J. R., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
The early spread and epidemic ignition of HIV-1 in human populations
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., et al. (2014) · Science · doi:10.1126/science.1256739 · Cited by 736
Janssen, R. S. (1998) · JAMA · doi:10.1001/jama.280.1.42 · Cited by 687
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane
Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G., & Engleman, E. G. (1987) · Cell · doi:10.1016/0092-8674(87)90542-3 · Cited by 627
A new human immunodeficiency virus derived from gorillas
Plantier, J.-C., Leoz, M., Dickerson, J. E., De Oliveira, F., Cordonnier, F., Lemée, V., Damond, F., Robertson, D. L., & Simon, F. (2009) · Nature Medicine · doi:10.1038/nm.2016 · Cited by 595
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
Simon, F., Mauclère, P., Roques, P., Loussert-Ajaka, I., Müller-Trutwin, M. C., Saragosti, S., Georges-Courbot, M. C., Barré-Sinoussi, F., & Brun-Vézinet, F. (1998) · Nature Medicine · doi:10.1038/2017 · Cited by 589
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Tracing the origin and history of the HIV-2 epidemic
Lemey, P., Pybus, O. G., Wang, B., Saksena, N. K., Salemi, M., & Vandamme, A.-M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0936469100 · Cited by 413
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon
Gürtler, L. G., Hauser, P. H., Eberle, J., von Brunn, A., Knapp, S., Zekeng, L., Tsague, J. M., & Kaptue, L. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1581-1585.1994 · Cited by 391
Martin, L. S., McDougal, J. S., & Loskoski, S. L. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.2.400 · Cited by 363
Crystal structure of bacteriophage T7 RNA polymerase at 3.3 Å resolution
Sousa, R., Chung, Y. J., Rose, J. P., & Wang, B.-C. (1993) · Nature · doi:10.1038/364593a0 · Cited by 361
Assembly and morphology of HIV: potential effect of structure on viral function
Gelderblom, H. R. (1991) · AIDS · doi:10.1097/00002030-199106000-00001 · Cited by 326
Santiago, M. L., Range, F., Keele, B. F., Li, Y., Bailes, E., Bibollet-Ruche, F., Fruteau, C., Noë, R., Peeters, M., Brookfield, J. F. Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12515-12527.2005 · Cited by 320
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
Altfeld, M., Allen, T. M., Yu, X. G., Johnston, M. N., Agrawal, D., Korber, B. T., Montefiori, D. C., O'Connor, D. H., Davis, B. T., Lee, P. K., et al. (2002) · Nature · doi:10.1038/nature01200 · Cited by 304
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT
Spire, B., Barré-Sinoussi, F., Dormont, D., Montagnier, L., & Chermann, J. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92026-4 · Cited by 295
Tebit, D. M., & Arts, E. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70186-9 · Cited by 280
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Archin, N. M., Sung, J. M., Garrido, C., Soriano-Sarabia, N., & Margolis, D. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3352 · Cited by 275
Understanding the genetic diversity of HIV-1.
McCutchan, F. E. (2000) · PubMed · Cited by 270
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells
Meng, G., Wei, X., Wu, X., Sellers, M. T., Decker, J. M., Moldoveanu, Z., Orenstein, J. M., Graham, M. F., Kappes, J. C., Mestecky, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-150 · Cited by 265
McDougal, J. S., Martin, L. S., Cort, S. P., Mozen, M., Heldebrant, C. M., & Evatt, B. L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112045 · Cited by 255
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Hepatitis B and C in HIV-infected patients
Ockenga, J., Tillmann, H. L., Trautwein, C., Stoll, M., Manns, M. P., & Schmidt, R. E. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80274-7 · Cited by 240
Vanden Haesevelde, M., Decourt, J. L., De Leys, R. J., Vanderborght, B., van der Groen, G., van Heuverswijn, H., & Saman, E. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1586-1596.1994 · Cited by 230
HIV-Positive–to–HIV-Positive Kidney Transplantation — Results at 3 to 5 Years
Muller, E., Barday, Z., Mendelson, M., & Kahn, D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408896 · Cited by 227
Leonard, J., Parrott, C., Buckler-White, A. J., Turner, W., Ross, E. K., Martin, M. A., & Rabson, A. B. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4919-4924.1989 · Cited by 209
Menéndez-Arias, L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.007 · Cited by 207
Feng, Y., He, X., Hsi, J. H., Li, F., Li, X., Wang, Q., Ruan, Y., Xing, H., Lam, T. T.-Y., Pybus, O. G., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328360db2d · Cited by 204
Genetic diversity of HIV-1: the moving target.
Peeters, M., & Sharp, P. M. (2000) · PubMed · Cited by 193
Response to the AIDS Pandemic — A Global Health Model
Piot, P., & Quinn, T. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201533 · Cited by 185
Zeng, M., Southern, P. J., Reilly, C. S., Beilman, G. J., Chipman, J. G., Schacker, T. W., & Haase, A. T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002437 · Cited by 182
Confirmation of Putative HIV-1 Group P in Cameroon
Vallari, A., Holzmayer, V., Harris, B., Yamaguchi, J., Ngansop, C., Makamche, F., Mbanya, D., Kaptué, L., Ndembi, N., Gürtler, L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02005-10 · Cited by 177
Locatelli, S., & Peeters, M. (2012) · AIDS · doi:10.1097/qad.0b013e328350fb68 · Cited by 165
Singh, Y., Sawyer, L. S., Pinkoski, L. S., Dupuis, K. W., Hsu, J. C., Lin, L., & Corash, L. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00867.x · Cited by 164
Restrictions to HIV-1 replication in resting CD4+ T lymphocytes
Pan, X., Baldauf, H., Keppler, O. T., & Fackler, O. (2013) · Cell Research · doi:10.1038/cr.2013.74 · Cited by 159
Detection of Low HIV-1 RNA Levels in Plasma
Schockmel, G. A., Yerly, S., & Perrin, L. H. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199702010-00013 · Cited by 156
Effect of age at seroconversion on the natural AIDS incubation distribution
Rosenberg, P. S., & Goedert, J. J. (1994) · AIDS · doi:10.1097/00002030-199406000-00013 · Cited by 153
HIV Infection with Seroconversion after a Superficial Needlestick Injury to the Finger
Oksenhendler, É., Harzic, M., Roux, J., Rabian, C., & Clauvel, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150912 · Cited by 153
Mohr, H., Steil, L., Gravemann, U., Thiele, T., Hammer, E., Greinacher, A., Müller, T. H., & Völker, U. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02334.x · Cited by 151
Dehne, K. L., Khodakevich, L., Hamers, F. F., et al. (1999) · AIDS · doi:10.1097/00002030-199905070-00002 · Cited by 144
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.
Jaffar, S. S., Grant, A. D., Whitworth, J. A. G., Smith, P. G., & Whittle, H. C. (2004) · Europe PMC (PubMed Central) · Cited by 141
HIV binding, penetration, and primary infection in human cervicovaginal tissue
Maher, D. M., Wu, X., Schacker, T. W., Horbul, J., & Southern, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500848102 · Cited by 139
Human Immunodeficiency Virus Type 1 Intergroup (M/O) Recombination in Cameroon
Takehisa, J., Zekeng, L. A., Ido, E., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6810-6820.1999 · Cited by 137
Aging, inflammation, and HIV infection.
Aberg, J. A. (2012) · Topics in antiviral medicine · Cited by 136
Herbein, G., Lint, C. M. V., Lovett, J. L., & Verdin, E. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.660-670.1998 · Cited by 135
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure
Lindbäck, S., Thorstensson, R., Karlsson, A. C., von Sydow, M. A. E., Flamholc, L., Blaxhult, A., Sönnerborg, A. B., Biberfeld, G., & Gaines, H. (2000) · AIDS · doi:10.1097/00002030-200010200-00014 · Cited by 133
Courgnaud, V., Salemi, M., Pourrut, X., Mpoudi‐Ngolé, E., Abela, B., Auzel, P., Bibollet‐Ruche, F., Hahn, B. H., Vandamme, A., Delaporte, É., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8298-8309.2002 · Cited by 131
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
the SPREAD Programme, Paraskevis, D. N., Pybus, O. G., Magiorkinis, G., Hatzakis, A. E., Wensing, A. M. J., van de Vijver, D. A. M. C., Albert, J., Angarano, G., Åsjö, B., et al. (2009) · Retrovirology · doi:10.1186/1742-4690-6-49 · Cited by 126
Robbins, K. E., Lemey, P., Pybus, O. G., Jaffe, H. W., Youngpairoj, A. S., Brown, T. M., Salemi, M., Vandamme, A., & Kalish, M. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6359-6366.2003 · Cited by 121
Esposito, F., Corona, A., & Tramontano, E. (2012) · Molecular Biology International · doi:10.1155/2012/586401 · Cited by 119
LOSS OF ENVELOPE ANTIGENS OF HTLV-III/LAV, A FACTOR IN AIDS PATHOGENESIS?
Gelderblom, H., Reupke, H., & Pauli, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90570-7 · Cited by 118
The HIV-1 Env Protein: A Coat of Many Colors
Arrildt, K. T., Joseph, S., & Swanstrom, R. I. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0107-3 · Cited by 114
Aghokeng, A., Ayouba, A., Mpoudi-ngole, E., Loul, S., Liégeois, F., Delaporte, E., & Peeters, M. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2009.04.014 · Cited by 111
Dichtelmüller, H. O., BIESERT, L., Fabbrizzi, F., Gajardo, R., Gröner, A., von Hoegen, I., Jorquera, J. I., Kempf, C., Kreil, T. R., Pifat, D. Y., et al. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02222.x · Cited by 106
Duwe, S. C., Brunn, M., Altmann, D., Hamouda, O., Schmidt, B., Walter, H., Pauli, G., & cherer, C. K. ⁄. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103010-00010 · Cited by 105
Photochemical Inactivation of DNA and RNA Viruses by Psoralen Derivatives
Hanson, C. V., Riggs, J. L., & Lennette, E. H. (1978) · Journal of General Virology · doi:10.1099/0022-1317-40-2-345 · Cited by 102
Management of chronic hepatitis C in HIV-infected patients
Soriano, V., Rodríguez-Rosado, R., & García‐Samaniego, J. (1999) · AIDS · doi:10.1097/00002030-199904010-00002 · Cited by 99
Progress in HIV-1 vaccine development
Haynes, B. F., Moody, M. A., Alam, M. S., Bonsignori, M., Verkoczy, L. K., Ferrari, G., Gao, F., Tomaras, G. D., Liao, H., & Kelsoe, G. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.025 · Cited by 96
Non-M Variants of Human Immunodeficiency Virus Type 1
Mourez, T., Simon, F., & Plantier, J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-13 · Cited by 96
Transmission networks of HIV-1 among men having sex with men in the Netherlands
Bezemer, D., van Sighem, A., Lukashov, V. V., van der Hoek, L., Back, N. K. T., Schuurman, R., Boucher, C. A., Claas, E. C. J., Boerlijst, M. C., Coutinho, R. A., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328333ddee · Cited by 93
Revealing the history of infectious disease epidemics through phylogenetic trees
Holmes, E. C., Nee, S., Rambaut, A., et al. (1995) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1995.0088 · Cited by 93
Pruss, A., Kao, M., Kiesewetter, H., von Versen, R., & Pauli, G. (1999) · Biologicals · doi:10.1006/biol.1999.0177 · Cited by 76
Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein
Sauter, D., Unterweger, D., Vogl, M., Usmani, S. M., Heigele, A., Kluge, S. F., Hermkes, E., Moll, M., Barker, E., Peeters, M., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003093 · Cited by 75
Schimpf, K., Brackmann, H. H., Kreuz, W., Kraus, B., Haschke, F., Schramm, W., Mösseler, J., Auerswald, G., Sutor, A. H., Koehler, K., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910263211702 · Cited by 74
Roques, P., Robertson, D. L., Souquière, S., et al. (2002) · Virology · doi:10.1006/viro.2002.1430 · Cited by 73
The next generation of the World Health Organization's global antiretroviral guidance
Hirnschall, G. O., Harries, A. D., Easterbrook, P., Doherty, M. C., & Ball, A. L. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.1.18757 · Cited by 72
HIV-2 Infection Surveillance--United States, 1987-2009.
(2011) · PubMed · Cited by 67
Rao, V. R., Neogi, U., Talboom, J. S., Padilla, L., Rahman, M., Fritz-French, C., González-Ramírez, S., Verma, A., Wood, C. A., Ruprecht, R. M., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-61 · Cited by 65
PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUS
Alter, H. J., Morel, P. A., Dorman, B. P., Smith, G. C., Creagan, R. P., Wiesehahn, G. P., Corash, L., Pópper, H., & Eichberg, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90931-2 · Cited by 64
Pauls, E., Jiménez, E., Ruiz, A., Permanyer, M., Ballana, E., Costa, H., Nascimiento, R., Parkhouse, R. M. E., Peña, R., Riveira‐Muñoz, E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203226 · Cited by 63
Immune interventions in HIV infection
Carcelain, G., & Autran, B. (2013) · Immunological Reviews · doi:10.1111/imr.12083 · Cited by 62
Effect of Antiretroviral Therapy on HIV Reservoirs in Elite Controllers
Chun, T., Justement, J. S., Murray, D., Kim, C. J., Blažková, J., Hallahan, C. W., Benko, E., Costiniuk, C. T., Kandel, G. P., Ostrowski, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit306 · Cited by 62
Rerks‐Ngarm, S., Paris, R., Chunsutthiwat, S., Premsri, N., Namwat, C., Bowonwatanuwong, C., Li, S. S., Kaewkungkal, J., Trichavaroj, R., Churikanont, N., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis478 · Cited by 61
A global approach to HIV ‐1 vaccine development
Stephenson, K. E., & Barouch, D. H. (2013) · Immunological Reviews · doi:10.1111/imr.12073 · Cited by 59
Journal of AIDS & Clinical Research
Kong, L., & Sattentau, Q. J. (2019) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113 · Cited by 59
Soriano, V., Vispo, E., Fernández-Montero, J. V., Labarga, P., & Barreiro, P. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0169-5 · Cited by 53
Niedrig, M., Gelderblom, H., Pauli, G., März, J., Bickhard, H., Wolf, H. J., & Modrow, S. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-6-1469 · Cited by 51
Pathogen inactivation and removal methods for plasma‐derived clotting factor concentrates
Klamroth, R., Gröner, A., & Simon, T. L. (2013) · Transfusion · doi:10.1111/trf.12423 · Cited by 50
Chudy, M., Weber‐Schehl, M., Pichl, L., Jork, C., Kreß, J., Heiden, M., Funk, M. B., & Nübling, C. M. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03281.x · Cited by 49
Dalmau, J., Puertas, M. C., Azuara, M., Mariño, A., Frahm, N., Mothe, B., Izquierdo‐Useros, N., Buzón, M. J., Paredes, R., Matas, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/595704 · Cited by 47
Chang, M., Gottlieb, G. S., Dragavon, J., Cherne, S., Kenney, D. L., Hawes, S. E., Smith, R. A., Kiviat, N. B., Sow, P. S., & Coombs, R. W. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.06.024 · Cited by 44
Loeb, M. B., Eskandarian, S., Rupp, M. E., Fishman, N. O., Gasink, L. B., PATTERSON, J. E., Bramson, J. L., Hudson, T. J., & Lemire, M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir493 · Cited by 43
Seroconversion to HIV-1 Following a Needlestick Injury Despite Combination Post-exposure Prophylaxis
HAWKINS, D. A., Asboe, D., Barlow, K. L., & EVANS, B. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0811 · Cited by 40
Molecular assays for monitoring HIV infection and antiretroviral therapy
Wittek, M., Stürmer, M., Doerr, H. W., et al. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.3.237 · Cited by 39
HIV infection among heterosexuals at increased risk--United States, 2010.
(2013) · PubMed · Cited by 38
Estimating the Rate of Intersubtype Recombination in Early HIV-1 Group M Strains
Ward, M. J., Lycett, S., Kalish, M. L., Rambaut, A., & Brown, A. (2012) · Journal of Virology · doi:10.1128/jvi.02478-12 · Cited by 36
Pathogen safety of plasma‐derived products – Haemate® P/Humate‐P®
Gröner, A. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01852.x · Cited by 36
Elite control of HIV: is this the right model for a functional cure?
Cockerham, L. R., & Hatano, H. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.11.003 · Cited by 35
How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing
Müller, B., Nübling, C. M., Kreß, J., Roth, W. K., Zolt, S. D., & Pichl, L. (2013) · Transfusion · doi:10.1111/trf.12298 · Cited by 30
Styer, L. M., Miller, T. T., & Parker, M. M. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.09.007 · Cited by 30
Phylodynamics of HIV-1 subtype F1 in Angola, Brazil and Romania
Bello, G., Afonso, J. M., & Morgado, M. G. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.03.014 · Cited by 30
Churchill, M. J., Chiavaroli, L., Wesselingh, S. L., & Gorry, P. R. (2007) · Retrovirology · doi:10.1186/1742-4690-4-43 · Cited by 30
Novel factors interfering with human immunodeficiency virus‐type 1 replication in vivo and in vitro
Vicenzi, E., & Poli, G. (2013) · Tissue Antigens · doi:10.1111/tan.12047 · Cited by 29
Bonner, K., Siemieniuk, R. A. C., Boozary, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113813 · Cited by 28
Katzenstein, T. L., Dickmeiss, E., Aladdin, H., Hede, A., Nielsen, C., Nielsen, H., Jørgensen, L. B., & Gerstoft, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00005 · Cited by 26
Demirkhanyan, L. H., Marin, M., Lu, W., & Melikyan, G. B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003431 · Cited by 24
Twenty-Five Years of Translational Medicine in Antiretroviral Therapy: Promises to Keep
Broder, S. E. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000749 · Cited by 23
Holmes, H. C., Berry, N. J., Heath, A., & Morris, C. L. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.05.025 · Cited by 17
Selhorst, P., Grupping, K., Tong, T., Crooks, E. T., Martin, L., Vanham, G., Binley, J. Μ., & Ariën, K. K. (2013) · Retrovirology · doi:10.1186/1742-4690-10-12 · Cited by 17
Developing pathogen reduction technologies for RBC suspensions
Wagner, S. J. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01386.x · Cited by 13
HIV transmission by needle stick and eczematous lesion — Three cases from Germany
Gürtler, L. G., Eberle, J., & Bader, L. (1993) · Infection · doi:10.1007/bf01739310 · Cited by 6
Cited by
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Hassett, K. J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C. J., Acosta, E., Almarsson, Ö., Moore, M. J., & Brito, L. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.021 · Cited by 367
Munawaroh, H. S. H., Gumilar, G. G., Pratiwi, R. N., Khoiriah, S. F., Ningrum, A., Martha, L., Chew, K. W., & Show, P.-L. (2024) · Algal Research · doi:10.1016/j.algal.2024.103468 · Cited by 9
Metadata
- Authors
- German Advisory Committee Blood (Arbeitskreis Blut), S. ‘. O. P. T. B. B.
- Venue
- Transfusion Medicine and Hemotherapy
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 43
- Issue
- 3
- Pages
- 203-222
- ISSN
- 1660-3796 (ISSN-L)
- 1660-3818
- OpenAlex
- W4244138569
- Cited by
- 355
- References
- 108
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.